open access

Vol 12, No 6 (2016)
Review paper
Published online: 2017-06-02
Get Citation

Is cetuximab in combination with irinotecan as a third-line treatment for advanced colorectal cancer scientifically justified?

Magdalena Krakowska1, Rafał Czyżykowski1, Piotr Potemski1
DOI: 10.5603/OCP.2016.0016
·
Oncol Clin Pract 2016;12(6):205-208.


Affiliations

  1. Department of Cancer Chemotherapy, Medical University in Lodz M. Kopernik Memorial WWCOiT in Lodz, Poland

open access

Vol 12, No 6 (2016)
REVIEW ARTICLES
Published online: 2017-06-02

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Is cetuximab in combination with irinotecan as a third-line treatment for advanced colorectal cancer scientifically justified?

Journal

Oncology in Clinical Practice

Issue

Vol 12, No 6 (2016)

Article type

Review paper

Pages

205-208

Published online

2017-06-02

DOI

10.5603/OCP.2016.0016

Bibliographic record

Oncol Clin Pract 2016;12(6):205-208.

Authors

Magdalena Krakowska
Rafał Czyżykowski
Piotr Potemski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl